Akademisyen
MERVE KARAYEL BAŞAR
DOKTOR ÖĞRETİM ÜYESİ
BAHÇEŞEHİR ÜNİVERSİTESİ TIP FAKÜLTESİ TEMEL TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Biyokimya
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 20
- Proje 0
- Kitap 0
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
12
Q2
8
Q3
0
Q4
0
WoS (JCR)
Q1
4
Q2
9
Q3
7
Q4
0
TR Index
2
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
4
Ort. yüzdelik
70.0%
Üst %1 payı
0.0%
Üst %10 payı
20.0%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2024 O-demethyl Galantamine Alters Protein Expression in Cerebellum of 5xFAD Mice YÖKSİS TR Index SJR Q2 JCR Q3 OpenAlex 4.6%
- 2024 O-demethyl Galantamine Alters Protein Expression in Cerebellum of 5xFAD Mice YÖKSİS TR Index SJR Q2 JCR Q3 OpenAlex 4.6%
- 2023 Detection of early proteomic alterations in 5xFAD Alzheimer's disease neonatal mouse model via MALDI-MSI YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 93.3%
- 2023 Detection of proteomic alterations at different stages in a Huntington's disease mouse model via matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) imaging YÖKSİS SJR Q2 JCR Q3 OpenAlex 54.1%
- 2023 Proteomic alterations in the cerebellum and hippocampus in an Alzheimer?s disease mouse model: Alleviating effect of palmatine YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 94.1%
- 2023 Detection of proteomic alterations at different stages in a Huntington's disease mouse model via matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) imaging YÖKSİS SJR Q2 JCR Q3 OpenAlex 54.1%
- 2023 Detection of early proteomic alterations in 5xFAD Alzheimer's disease neonatal mouse model via MALDI-MSI YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 93.3%
- 2022 Spatial proteomic alterations detected via MALDI-MS imaging implicate neuronal loss in a Huntington's disease mouse (YAC128) brain YÖKSİS SJR Q2 JCR Q3 OpenAlex 61.9%
- 2022 Spatial proteomic alterations detected via MALDI-MS imaging implicate neuronal loss in a Huntington's disease mouse (YAC128) brain YÖKSİS SJR Q2 JCR Q3 OpenAlex 61.9%
- 2022 Molecular Effects of Pteryxin and Scopoletin in the 5xFAD\nAlzheimer\u2019s Disease Mouse Model YÖKSİS SJR Q1 JCR Q2 OpenAlex 90.0%
- 2022 Molecular Effects of Pteryxin and Scopoletin in the 5xFAD Alzheimer's Disease Mouse Model YÖKSİS SJR Q1 JCR Q2 OpenAlex 90.0%
- 2021 Evaluation of the Therapeutic Effect of Lycoramine on Alzheimer's Disease in Mouse Model YÖKSİS SJR Q1 JCR Q2 OpenAlex 66.2%
- 2021 Evaluation of the Therapeutic Effect of Lycoramine on Alzheimer's Disease in Mouse Model YÖKSİS SJR Q1 JCR Q2 OpenAlex 66.2%
- 2019 Proteomics Analysis of CA1 Region of the Hippocampus in Pre-, Progression and Pathological Stages in a Mouse Model of the Alzheimer's Disease YÖKSİS SJR Q2 JCR Q2 OpenAlex 75.2%
- 2018 Early Stage Alterations in CA1 Extracellular Region Proteins Indicate Dysregulation of IL6 and Iron Homeostasis in the 5XFAD Alzheimer's Disease Mouse Model YÖKSİS SJR Q1 JCR Q2 OpenAlex 89.6%
- 2018 Early Stage Alterations in CA1 Extracellular Region Proteins Indicate Dysregulation of IL6 and Iron Homeostasis in the 5XFAD Alzheimer's Disease Mouse Model YÖKSİS SJR Q1 JCR Q2 OpenAlex 89.6%
- 2023 Proteomic alterations in the cerebellum and hippocampus in an Alzheimer?s disease mouse model: Alleviating effect of palmatine YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 94.1%
- 2022 Spatial proteomic alterations detected via MALDI-MS imaging implicate neuronal loss in a Huntington's disease mouse (YAC128) brain YÖKSİS SJR Q2 JCR Q3 OpenAlex 61.9%
- 2022 Molecular Effects of Pteryxin and Scopoletin in the 5xFAD Alzheimer's Disease Mouse Model YÖKSİS SJR Q1 JCR Q2 OpenAlex 90.0%
- 2021 Evaluation of the Therapeutic Effect of Lycoramine on Alzheimer\u2019s Disease in Mouse Model YÖKSİS SJR Q1 JCR Q2 OpenAlex 66.2%